找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Recent Advances and Challenges in the Treatment of Major Depressive Disorder; Yong-Ku Kim Book 2024 The Editor(s) (if applicable) and The

[复制链接]
查看: 34054|回复: 57
发表于 2025-3-21 17:43:11 | 显示全部楼层 |阅读模式
书目名称Recent Advances and Challenges in the Treatment of Major Depressive Disorder
编辑Yong-Ku Kim
视频video
概述Provides up-to-date understanding of neurobiological mechanisms and therapeutic strategies of MDD.Describes recent advances and challenges in the treatment for MDD.Reviews pharmacotherapy, psychologic
丛书名称Advances in Experimental Medicine and Biology
图书封面Titlebook: Recent Advances and Challenges in the Treatment of Major Depressive Disorder;  Yong-Ku Kim Book 2024 The Editor(s) (if applicable) and The
描述.This book reviews all aspects of major depressive disorder (MDD), casting light on its neurobiological underpinnings and describing the most recent advances in management. The book is divided into four sections, the first of which discusses MDD from a network science perspective, highlighting the alterations in functional and structural connectivity and presenting insights achieved through resting state functional MRI and the development of neuroimaging-based biomarkers. The second section examines important diagnostic and neurobiological issues, while the third considers the currently available specific treatments for MDD, including biofeedback, neurofeedback, cognitive behavioral therapy, acceptance and commitment therapy, neuromodulation therapy, psychodynamic therapy, and complementary and alternative medicine. A concluding section is devoted to promising emerging treatments, from novel psychopharmacological therapies through to virtual reality treatment, immunotherapy, biomarker-guided tailored therapy, and more. Written by leading experts from across the world, the book will be an excellent source of information for both researchers and practitioners..
出版日期Book 2024
关键词Antidepressant; Neuroinflammation; Pathophysiology; Depression; Ketamine
版次1
doihttps://doi.org/10.1007/978-981-97-4402-2
isbn_softcover978-981-97-4404-6
isbn_ebook978-981-97-4402-2Series ISSN 0065-2598 Series E-ISSN 2214-8019
issn_series 0065-2598
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor
The information of publication is updating

书目名称Recent Advances and Challenges in the Treatment of Major Depressive Disorder影响因子(影响力)




书目名称Recent Advances and Challenges in the Treatment of Major Depressive Disorder影响因子(影响力)学科排名




书目名称Recent Advances and Challenges in the Treatment of Major Depressive Disorder网络公开度




书目名称Recent Advances and Challenges in the Treatment of Major Depressive Disorder网络公开度学科排名




书目名称Recent Advances and Challenges in the Treatment of Major Depressive Disorder被引频次




书目名称Recent Advances and Challenges in the Treatment of Major Depressive Disorder被引频次学科排名




书目名称Recent Advances and Challenges in the Treatment of Major Depressive Disorder年度引用




书目名称Recent Advances and Challenges in the Treatment of Major Depressive Disorder年度引用学科排名




书目名称Recent Advances and Challenges in the Treatment of Major Depressive Disorder读者反馈




书目名称Recent Advances and Challenges in the Treatment of Major Depressive Disorder读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:03:08 | 显示全部楼层
978-981-97-4404-6The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor
发表于 2025-3-22 02:16:22 | 显示全部楼层
Recent Advances and Challenges in the Treatment of Major Depressive Disorder978-981-97-4402-2Series ISSN 0065-2598 Series E-ISSN 2214-8019
发表于 2025-3-22 05:35:54 | 显示全部楼层
发表于 2025-3-22 10:31:04 | 显示全部楼层
https://doi.org/10.1007/978-981-97-4402-2Antidepressant; Neuroinflammation; Pathophysiology; Depression; Ketamine
发表于 2025-3-22 15:56:22 | 显示全部楼层
Induce Pluripotent Stem Cells (iPSC) Technology in Depressionressive disorders (MDD). In this chapter, we explore different uses for iPSC technology, three-dimensional (3D) organoids models, and mesenchymal stem cells therapy in MDD, as well their potential and limitations.
发表于 2025-3-22 19:05:10 | 显示全部楼层
发表于 2025-3-22 22:23:57 | 显示全部楼层
Marie Drüge,Lisa Guthardt,Elisa Haller,Johannes Michalak,Jennifer Apolinário-Hagen
发表于 2025-3-23 04:18:37 | 显示全部楼层
发表于 2025-3-23 06:17:32 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-20 09:46
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表